Peter G. Klimko

636 total citations
17 papers, 426 citations indexed

About

Peter G. Klimko is a scholar working on Pharmacology, Organic Chemistry and Ophthalmology. According to data from OpenAlex, Peter G. Klimko has authored 17 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Organic Chemistry and 5 papers in Ophthalmology. Recurrent topics in Peter G. Klimko's work include Inflammatory mediators and NSAID effects (7 papers), Glaucoma and retinal disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Peter G. Klimko is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Glaucoma and retinal disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Peter G. Klimko collaborates with scholars based in United States, Switzerland and China. Peter G. Klimko's co-authors include Najam A. Sharif, Brenda Walker Griffin, Julie Y. Crider, Daniel A. Singleton, Charles S. Swindell, Mark R. Hellberg, Weiming Fan, Tom R. Dean, Gustav Graff and Marsha A. McLaughlin and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Peter G. Klimko

17 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter G. Klimko United States	12	136	125	118	93	62	17	426
Jennifer Lafontaine United States	12	218 1.6×	176 1.4×	66 0.6×	67 0.7×	30 0.5×	17	458
Charlotta Liljebris Sweden	7	144 1.1×	203 1.6×	72 0.6×	46 0.5×	41 0.7×	12	402
Whei‐Mei Wu United States	13	41 0.3×	148 1.2×	86 0.7×	39 0.4×	86 1.4×	20	398
Madhu Sudhana Saddala United States	15	100 0.7×	191 1.5×	120 1.0×	30 0.3×	16 0.3×	42	515
Kenichi Kïshida Japan	10	41 0.3×	230 1.8×	66 0.6×	27 0.3×	14 0.2×	26	352
Andrew Payne United Kingdom	11	76 0.6×	151 1.2×	30 0.3×	14 0.2×	21 0.3×	22	408
Debra K. Breuer United States	5	29 0.2×	213 1.7×	57 0.5×	103 1.1×	7 0.1×	5	394
Masami Shiratsuchi Japan	9	78 0.6×	182 1.5×	25 0.2×	50 0.5×	6 0.1×	20	345
Aikaterini Nikolaou Greece	9	55 0.4×	196 1.6×	15 0.1×	44 0.5×	29 0.5×	12	329
Paul A. Mieyal United States	9	14 0.1×	241 1.9×	36 0.3×	94 1.0×	49 0.8×	10	460

Countries citing papers authored by Peter G. Klimko

Since Specialization

Citations

This map shows the geographic impact of Peter G. Klimko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter G. Klimko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter G. Klimko more than expected).

Fields of papers citing papers by Peter G. Klimko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter G. Klimko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter G. Klimko. The network helps show where Peter G. Klimko may publish in the future.

Co-authorship network of co-authors of Peter G. Klimko

This figure shows the co-authorship network connecting the top 25 collaborators of Peter G. Klimko. A scholar is included among the top collaborators of Peter G. Klimko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter G. Klimko. Peter G. Klimko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Sharif, Najam A. & Peter G. Klimko. (2018). Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility. British Journal of Pharmacology. 176(8). 1059–1078. 32 indexed citations

2.

Klimko, Peter G. & Najam A. Sharif. (2018). Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. British Journal of Pharmacology. 176(8). 1051–1058. 43 indexed citations

3.

Pfister, Sandra L., et al.. (2016). (5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic acid: A stable isomer of 15(S)-HETE that retains key vasoconstrictive and antiproliferative activity. Prostaglandins & Other Lipid Mediators. 123. 33–39. 1 indexed citations

4.

Sharif, Najam A. & Peter G. Klimko. (2009). Update and commentary on the pro-drug bimatoprost and a putative ‘prostamide receptor’. Expert Review of Ophthalmology. 4(5). 477–489. 15 indexed citations

5.

Mohapatra, Suchismita, Peter G. Klimko, Mark R. Hellberg, et al.. (2007). Novel benzodifuran analogs as potent 5-HT2A receptor agonists with ocular hypotensive activity. Bioorganic & Medicinal Chemistry Letters. 17(11). 2998–3002. 28 indexed citations

6.

Klimko, Peter G., Mark R. Hellberg, Marsha A. McLaughlin, et al.. (2004). 15-Fluoro prostaglandin FP agonists: a new class of topical ocular hypotensives. Bioorganic & Medicinal Chemistry. 12(13). 3451–3469. 18 indexed citations

7.

Hellberg, Mark R., Najam A. Sharif, Marsha A. McLaughlin, et al.. (2004). AL-12182, a novel 11-oxa prostaglandin analog with topical ocular hypotensive activity in the monkey. Bioorganic & Medicinal Chemistry Letters. 14(17). 4525–4528. 7 indexed citations

8.

Hellberg, Mark R., et al.. (2003). The Hydrolysis of the Prostaglandin Analog Prodrug Bimatoprost to 17-Phenyl-trinor PGF _{2 α} by Human and Rabbit Ocular Tissue. Journal of Ocular Pharmacology and Therapeutics. 19(2). 97–103. 39 indexed citations

9.

Klimko, Peter G., Terry L. Davis, Brenda Walker Griffin, & Najam A. Sharif. (2000). Synthesis and Biological Activity of a Novel 11a-Homo (Cyclohexyl) Prostaglandin. Journal of Medicinal Chemistry. 43(18). 3400–3407. 9 indexed citations

10.

Griffin, Brenda Walker, Peter G. Klimko, Julie Y. Crider, & Najam A. Sharif. (1999). AL-8810: A Novel Prostaglandin F2α Analog with Selective Antagonist Effects at the Prostaglandin F2α (FP) Receptor. Journal of Pharmacology and Experimental Therapeutics. 290(3). 1278–1284. 53 indexed citations

11.

Griffin, Brenda Walker, Peter G. Klimko, Julie Y. Crider, & Najam A. Sharif. (1999). AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.. PubMed. 290(3). 1278–84. 86 indexed citations

12.

Swindell, Charles S., et al.. (1996). Taxane Synthesis through Intramolecular Pinacol Coupling at C-1−C-2. Construction and Oxidative Transformations of a C-Aromatic Taxane Diene. The Journal of Organic Chemistry. 61(15). 5190–5190. 1 indexed citations

13.

Swindell, Charles S., et al.. (1996). Taxane Synthesis through Intramolecular Pinacol Coupling at C-1−C-2. Construction and Oxidative Transformations of a C-Aromatic Taxane Diene. The Journal of Organic Chemistry. 61(3). 1101–1108. 20 indexed citations

14.

Swindell, Charles S., Weiming Fan, & Peter G. Klimko. (1994). Pinacol closure of oxygenated taxane skeleta at C-1-C-2 with stereoinduction by oxygen substituents at C-9 and C-10. Tetrahedron Letters. 35(28). 4959–4962. 24 indexed citations

15.

Klimko, Peter G. & Daniel A. Singleton. (1994). Extended Stereocontrol in Silyl Group-Transfer Cyclizations: Control of Four Contiguous Chiral Centers. Synthesis. 1994(9). 979–982. 5 indexed citations

16.

Swindell, Charles S., et al.. (1993). An AC → ABC approach to taxol involving B-ring closure at C-1–C-2. Tetrahedron Letters. 34(44). 7005–7008. 14 indexed citations

17.

Klimko, Peter G. & Daniel A. Singleton. (1992). Silyl group-transfer-mediated serial Michael additions. The Journal of Organic Chemistry. 57(6). 1733–1740. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact